Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus

Clinical trial NCT05247203 · COMPLETED

Trial details

NCT number: NCT05247203
Sponsor: RemeGen Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2022-05-11
Primary completion: 2023-10-25
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.